ACTISOUFRE, solution as a nasal spray/oromucosal in a pressurised container bottle, 100 ml
Active ingredients: Saccharomyces cerevisiae, MONOSULFURE DE SODIUM ANHYDRE, SODIUM (SULFURE DE) NONAHYDRATÉ
Commercialized according to BDPM
Solution for sprayingbottle, 100 mlnasale;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale;orale
- Presentation description
- 1 flacon(s) pressurisé(s) aluminium de 100 ml avec embout(s) polyéthylène polypropylène polyoxyméthylène
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Oct 2003
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67928230CIP73516715CIP133400935167156Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (SULFURE DE) NONAHYDRATÉsolution | — | SA |
| LEVUREsolution | 500 mg · 100 ml | SA |
| MONOSULFURE DE SODIUM ANHYDREsolution | 13 mg · 100 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.